Document is current

Article History

Received: 21 July 2023

Accepted: 11 February 2024

First Online: 22 February 2024

Declarations

:

: The study was approved by the Clinical Research Ethics Committee of Bellvitge (Code PR112/21). Patients or the public were not involved in the design, or conduct, or reporting, or dissemination plans of our research.

: Informed consent was obtained from all individual participants included in the study.

: The authors have no relevant financial or non-financial interests to disclose.